Life365 Engages Objective Capital Partners to Assist in Coordinating Strategic Capital and Partnership Opportunities

Life365, a leader in intelligent digital health infrastructure development and solution delivery, today announced that it has engaged Objective Capital Partners, LLC, to serve as a financial advisor to assist the Company in coordinating strategic capital and partnerships with the goal of maximizing the value of the strong intellectual property portfolio and digital health platform. The Life365 platform currently offers a range of solutions to engage health consumers at home, including a patented operating system for wearable health technology, software apps, integration to hundreds of connected medical devices, OTT set top box integration for Smart TVs, mobile / concierge personal safety services, Rapid Diagnostics pharmacy / home integration, and subscription e-commerce solutions for personalized care management.

Objective Capital Partners will be leading the process of identifying and securing either strategic capital financing and/or partnerships to progress Life365’s strong patent portfolio. Life365 already has a variety of market-validated partnerships including American Medical Response (AMR), OSANG Healthcare and Humax, a leader in OTT Set Top boxes in 90 countries.   Life365 is currently in various stages of on-boarding large enterprise clients that will align to form a unified digital health platform connecting healthcare consumers at home and changing the economics of healthcare.

“Our experienced team has been in the digital health space for the past 12 years and we’re now witnessing the convergence of large, trillion dollar channels with retail, distribution and tech companies aligning to address much larger patient populations,” said Kent Dicks, CEO of Life365. “Over the years many competitors have found that connecting to the consumer’s home is economically challenging – especially logistics for deployment, maintenance and refurbishment of equipment.  This has prevented current Remote Patient Monitoring solutions from scaling to a broad serviceable population. Like other industries, today’s health and care solutions need to be “Lite” and in essence disposable, with seamless, rapid and economic integration that engages consumers on their terms, driving a stronger ROI for enterprises connecting to growing populations.”

“We are excited to represent Life365 team at this time, as we witness an expansion of the market to drive the connected healthcare patient consumer. The Company has a compelling vision, management pedigree and IP assets that serves as an accelerator for enterprise clients,” said David H. Crean, Managing Director of Objective Capital Partners. “The Company’s Digital Health Platform connecting to the home continues to have great validation with the recent acquisition of Qualcomm Life, Inc. by private equity player, Francisco Partners. Platforms connecting into the home continue to allow healthcare the best opportunity to scale, including GreatCall being acquired by GTCR LLC and, ultimately, Best Buy.”

Inquiries regarding the Company’s intellectual property portfolio and programs may be directed either to the Company or to Objective Capital Partners.

About Life365

Life365’s connected health platform facilitates technology deployment that enables healthcare systems to scale self-managed patient care solutions to the home. Life365 integrates devices, software applications, and patient engagement tools to enable improved health outcomes, operational efficiencies, and lower healthcare costs. Life365’s team members have over a decade of experience in remote patient monitoring technology and are leaders in the industry. Life365 is based in Tempe, Arizona. For more information regarding Life365, please visit

About Objective Capital Partners

Objective Capital Partners, LLC is a leading investment banking firm focused on transactions for privately held companies with enterprise values up to $250 million. Objective Capital offers advisory services ranging from M&A business sale transactions, strategic partnerships, capital financing and business valuations. Founded in 2006, Objective’s seasoned professionals have collectively executed over 500 M&A and advisory engagements within its four industries of focus. Objective Capital is fiercely committed to helping entrepreneurs and business owners maximize the value of their business. For more information on Objective Capital Partners, please visit

Forward Looking Statements:

This press release contains “forward-looking statements” regarding matters that are not historical facts. Words describing the engagement of Objective Capital and the section “About Life365” include such words as “goal,” “development,” “potential,” “selling,” “could,” “will,” “soliciting,” “evaluating,” and “seeks,” and similar expressions, and are intended to identify forward-looking statements. These forward-looking statements are based upon current expectations of the Company and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. We undertake no obligation to update forward-looking statements contained in this press release.


The principals of Objective Capital Partners, LLC are registered representatives of BA Securities, LLC Member FINRA SIPC, located at Four Tower Bridge, 200 Barr Harbor Drive, Suite 400 W. Conshohocken, PA 19428. Objective Capital Partners, LLC and BA securities, LLC are unaffiliated entities. All investment banking services and securities are offered through BA Securities, LLC, Member FINRA SIPC.

Life365 Contact:

Kent Dicks, Chief Executive Officer


Objective Capital Partners Contact:

David H. Crean, Ph.D., Managing Director, Healthcare & Life Sciences

Posted in AZBio News.